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Protein synthesis and degradation in skeletal muscle of chronically
uremic rats. We used the perfused hemicorpus preparation to measure
individual rates of protein synthesis and degradation. Using fed ani-
mals, perfused either with or without insulin, muscle protein synthesis
and hemicorpus protein degradation rates were similar, but myofibrillar
protein degradation was clearly increased in the uremic preparations.
When the animals were fasted, differences in the rates of skeletal
muscle protein turnover were apparent. Uremic rats lost more wt at
both 24 and 48 hr of fasting when compared to either ad libidum fed or
pair—fed controls who started fasting at body wts equivalent to our
uremic rats. The accelerated wt loss was accompanied by lower rates of
protein synthesis, higher degradation rates, and greater net protein
catabolism in our uremic rats. Alterations in body lipid content were
present in uremia and correlated with the rate of protein degradation in
both control and uremic rats. These data demonstrated that even in the
fed state, uremia is associated with subtle alterations in skeletal muscle
protein turnover. When stressed, these alterations become more pro-
nounced. Insufficient stores of body lipids, either due to inadequate
nutrition or altered metabolism, may contribute to the alterations in
muscle protein turnover seen in chronic renal insufficiency.
Uremia is a multifaceted symptom complex in which a
number of metabolic abnormalities are commonly seen; glucose
intolerance [1]; insulin resistance [2]; altered lipid metabolism
[3]; and abnormal plasma amino acid concentrations [4] have all
been reported. Skeletal muscle is the body's largest tissue mass
and it is likely that these metabolic abnormalities would affect
that tissue as well. Individuals with chronic renal failure have
decreased muscle mass [5] and diminished muscle concentra-
tions of alkali—soluble proteins [61. In addition, several studies
have reported that the peripheral tissues (primarily muscle) are
responsible for both the abnormal glucose metabolism and
resistance to insulin seen in uremia [2,7]. Thus, a better
understanding of the response of muscle to the uremic state is
vital to our understanding of this condition.
For studies of the effects of uremia on skeletal muscle, two
rat models have been employed. Acute renal failure has been
induced by surgical bilateral nephrectomy [7,8] or ureteral
ligation [9]; and chronic renal insufficiency has been produced
by two—stage partial nephrectomy [10]. Acutely uremic rats are
not in a physiologic steady—state. In addition to severe uremia,
significant alterations in serum electrolyte values, surgical
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trauma and partial or total food deprivation are complicating
factors. In the face of these confounding factors, it is not certain
how the metabolic alterations seen in acute renal failure relate
to chronic renal insufficiency. The chronically uremic rat model
attempts to overcome these problems by studying the animals
several weeks post-surgery, at a time when they are eating,
growing and their tissues have had time to adapt to the presence
of high concentrations of retained metabolic waste products.
In a previous in vivo study [11] utilizing the urinary excretion
of Nt-methylhistidine, we documented the presence of acceler-
ated myofibrillar degradation rates in chronically uremic, fasted
rats when compared to fasted control animals. In our fed
animals, the urinary N'-methylhistidine/creatinine ratios were
also higher in the uremic rats. Because of the variable amount
of endogenous creatinine metabolism present in uremia we
were uncertain as to whether this implied an increase in
myofibrillar degradation in fed animals as well. Subsequent,
more detailed studies from this [12] and other laboratories [13,
14] have shed doubt on the interpretation of studies based solely
upon urinary methylhistidine excretion. Although skeletal mus-
cle contains most of the body's Ntmethylhistidine, the
actomyosin present within the gastrointestinal tract is degraded
much more rapidly than that present within skeletal muscle, so
that the GI tract may contribute up to 40% of the Nt
methylhistidine present in the urine of normal, fed rats [12]. No
data are available for the uremic rat detailing on the percent-
age contribution of the gastrointestinal tract to whole body
Ntmethylhistidine release either in the fed state or during
starvation.
In order to more directly examine the effects of uremia on
skeletal muscle, and eliminate the presence of gastrointestinal
tissue, we utilized the hemicorpus perfusion system to study
protein turnover. This preparation is well suited for the assess-
ment of protein turnover for several important reasons. It is
representative of the peripheral tissues of the rat, containing
mostly skeletal muscle [15]. The tissues from uremic and
control rats are perfused with identical perfusate which permits
distinction between alterations within muscle and the effects of
circulating factors on the muscle. This perfused preparation
allows for simultaneous independent measurements of protein
synthesis, protein degradation and net protein catabolism [15,
16]. In addition, we have successfully utilized this preparation
for the study of Ntmethylhistidine degradation rates in our
eviscerated preparation without the confounding presence of
gastrointestinal tissue [12].
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Because of the importance of previous nutritional intake and
wt gain on the rates of protein turnover, we felt that at least two
control groups were required, in addition to the standard
control group fed ad libitum, we also studied sham—operated
rats fed the same amount of rat chow eaten by their uremic
mates one day previously (pair—fed controls). Protein turnover
was assessed in the unperturbed, fed state and after the rats had
been stressed by moderate starvation. Our studies confirm that,
in chronic renal failure, protein degradation is accelerated in
both the fed and fasted states. Further, we suggest that this is
related to the decreased fat stores present within the uremic
animals which limits their ability to conserve protein during
periods of stress.
Methods
Rats
Male Sprague—Dawley rats were obtained from Charles River
Breeding Laboratories (Wilmington, Massachusetts, USA) as
weanlings and maintained on rat chow (Agway Formula 3000,
22% protein) and water ad libitum. All surgeries were per-
formed with the animals under ether anesthesia. Young rats (85
g) underwent right nephrectomy followed three days later by a
second operation involving the removal of both the upper and
lower poles and lateral surface of the left kidney. Two weeks
after the second surgery, the plasma urea nitrogen levels were
measured to assess the degree of uremia. Uremic rats were used
between two and three weeks after surgery. Sham-operated
control rats were prepared at the same time as the uremic
animals. Pair—fed control rats were sham-operated animals
which were subsequently fed the amount of food eaten by the
uremic member of the pair. In the starvation study, food was
removed from the cages 24 or 48 hr before the start of the in
vitro experiment. The rats had access to water throughout the
period of starvation.
Body composition
The rats were anesthetized. Blood was drawn from the
descending aorta and carcass wts were obtained after eviscer-
ation. This wt represented the peripheral tissues, mostly muscle
[11]. Total lipid and total protein content of the carcass without
the skin were determined by homogenization of the skinned
carcass in three volumes of distilled water. Weighed aliquots
were frozen for the analyses.
Perfused hemicorpus preparation
The hemicorpus preparation, the eviscerated lower half of a
rat, was perfused according to the previously described method
of Jefferson, Li, and Rannels [15, 161. Briefly, rats were injected
with 500 to 750 units of heparin and then anesthetized with 6.5
mg/l00 g BW of sodium pentobarbital. The arteries and veins to
the visera and endocrine glands were ligated. A cannula was
placed in the aorta at the level of the diaphragm. Perfusate
exited from the cut vena cava. After the body was transected,
the viscera were removed. The first 50 mliter of perfusate to
pass through the preparation were discarded and then 100 muter
of perfusate were recirculated at a flow rate of 14 mliter/min.
The perfusate consisted of Krebs—Henseleit bicarbonate
buffer, 3% bovine serum albumin (Fraction V, Miles Laborato-
ries, Elkhart, Indiana, USA), sufficient washed bovine erythro-
cytes for a 25% hematocrit, 16 mM glucose, and normal plasma
levels of amino acids [16]. In some studies, crystalline insulin
was added to the perfusate to achieve a concentration of 25
mU/muter. Phenylalanine (phe) was used to monitor protein
synthesis and degradation in the in vitro perfusion, since it is
neither synthesized nor catabolized in skeletal muscle [16]. Five
times normal plasma levels of phenylalanine (0.4 mM) were
utilized to promote the equilibration of ['4C] phenylalanine into
muscle and to prevent preferential reutilization of ['2C] phen-
ylalanine released from protein for protein synthesis [16].
Before the perfusion was started, blood was drawn from the
portal vein and plasma obtained for urea nitrogen and creatinine
determinations. At 1 and 3 hr of perfusion, a sample of
perfusate was obtained, centrifuged and the plasma saved. At
the same time one gastrocnemius muscle was biopsied and
frozen with Wollenberger clamps cooled in liquid nitrogen.
Protein synthesis rates were calculated as the difference in
DPM phenylalanine incorporated into gastrocnemius protein
between one and three hr of perfusion, divided by the mean
intracellular specific activity of phenylalanine determined at
those time points. The results are expressed as nanomoles
phenylalanine incorporated/gram gastrocnemius muscle/hour
[16].
Protein degradation at 1 or 3 hr was determined using the
following equations and the assumption that during the course
of a three hr perfusion, the recycling of labelled phenylalanine
would be minimal so that any decrease in phenylalanine specific
activity must be due to the release of unlabeled phenylalanine
from protein. The total DPM and nanomoles of unbound
phenylalanine were determined at 1 and 3 hr of perfusion. Since
protein synthesis will not change phenylalanine specific activ-
ity, total protein degradation by the hemicorpus is reflected in a
decrease in specific activity during the two hr interval. The
results are expressed as nanomoles phenylalanine released/g
hemicorpus/hour [16]. This figure represents degradation alone
and is not influenced by the ongoing rates of protein synthesis.
Total Phe = nmole Phe/g tissue x wt HC + (nmole Phe/mliter
perfusate x 100 mliter perfusate)
Total DPM = DPM/g tissue x wt HC + (DPM/mliter perfusate
x 100 mliter perfusate)
Protein Deg. = (((total DPMIh1Jtotal DPM3hr) x total Phe3hr)
— total phelhr)/2/HC wt
Net release of phenylalanine was calculated as the sum of
changes in phenylalanine content in muscle and perfusate
between 1 and 3 hr. It is a measure of the nitrogen balance in the
in vitro preparation [16].
Net Phe Release = (total phe3hr — total Phelhr)/2/wt HC
Myofibrillar protein degradation was calculated in a manner
analogous to that of net protein degradation and the change in
both total perfusate and muscle Ntmethylhistidine content
determined [12]. It should be noted that since protein synthesis
rates are calculated/gram gastrocnemius muscle and degrada-
tion rates determined/gram hemicorpus, the rates are not
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strictly comparable. In addition, net release is calculated inde-
pendently of synthesis and degradation and is not simply the
arithmetic difference between the two values. Our perfusions
were performed over a period of at least one year. To decrease
the variability in our studies, for each experiment hemicorpuses
obtained from uremic animals were always perfused with, and
results evaluated against, a single type of control.
Analyses
Plasma urea nitrogen concentrations were determined in
samples of blood and perfusate by a urease method (Sigma kit
640). Plasma creatinine concentrations were measured with a
Beckman Creatinine Analyzer II (Beckman Instruments, Ful-
lerton, California, USA).
Before analyses, muscle samples were powdered with a
mortar and pestle cooled in liquid nitrogen. Both perfusate
plasma and muscle powder were deproteinized with trichloro-
acetic acid (TCA). Radioisotopes were quantitated in aliquots
of the TCA supernatants by liquid scintillation counting in ACS
II (Amersham) in a Packard Tricarb counter. Quench correc-
tions were made using external standardization.
Total lipids were extracted from a homogenate of carcass
according to Bligh and Dyer and quantitated gravitimetrically
[17]. Total protein was determined on proteins solubilized in 1
N NaOH at 50°C by the biuret method [181 using crystalline
bovine albumin as standard.
Phenylalanine was analyzed by high performance liquid chro-
matography. This method was adapted [19] as follows: extracts
of muscle and perfusate in 5% TCA were injected onto a
uBondapak C18 (Waters Associates, Milford, Massachusetts,
USA) column and phenylalanine was eluted with 5 mrvt 1-
heptanesulfonic acid (Sigma, St. Louis, Missouri, USA), 1%
glacial acetic acid and 8% acetonitrile. Post-column, the eluent
was derivatized with 3.7 mi o-phthalaldehyde (Sigma) in 0.4
M B203, 0.5 mii 2-mercaptoethanol at pH Il. This solution
was pumped through a mixing, reaction coil at I mliter/min.
The fluorescence was measured and quantitated by external
standardization.
N'-Methylhistidine was determined by our previously de-
scribed HPLC method [20], The N'-methylhistidine in TCA
extracts of muscle and perfusate were derivatized with
fluorescamine, chromatographed on a uBondapak C18 column
with 23% acetonitrile and water. N'-methylhistidine release
from protein, a measure of protein degradation, was calculated
as the sum of changes in the perfusate and the muscle [12].
Statistics. Students t-test, least squares linear regression and
one—way analysis of variance (ANOVA) were used. A P value
of less than 0.05 was considered significant.
Results
The weight gain of control and uremic rats is presented in
Figure 1. The first operation was either a total right nephrec-
tomy or a sham operation in which the kidney was manipulated
and returned unharmed. Three days later the partial nephrec-
tomy or second sham nephrectomy was performed. Weight
gains indicated that surgical trauma in the uremic rats slowed wt
gain more than in controls during the first few days after
surgery, but the rats recovered by four days post-operatively.
Both groups grew at linear rates from 4 to 17 days post-
operatively. The controls grew slightly faster, at a rate of 7.1
—2 0 2 4 6 8 10 12 14 16 18
Time, days after nephrectomy
Fig. 1. Weight gain in chronically uremic and sham-operated rats. The
body wts of uremic and sham—operated rats were measured immedi-
ately before the first and second surgeries, and then at intervals of
several days. Rats were fed ad libitum.
Urea nitrogen (mM)
SHAM UREMIC
Fed 5.9 0.3° 23.5 13"
Fasted 48 hr 9.5 0.9 45.6 36""
Creatinine (mM)
Fed 0.023 0.002 0.090 0.005"
Fasted 48 hr 0.029 0.002 0.069 0.005l)1
g/day while the uremics grew at a rate of 5.0 g/day (P < 0.05).
As a result, when the rats were sacrificed, the uremic rats
weighed about 70% as much as the ad libitum fed controls.
Two to three weeks after surgery blood was drawn and
plasma analyzed for urea nitrogen and creatinine. The results
were presented in Table 1. Fed uremic rats had urea nitrogen
and creatinine concentrations about four times higher than
control animals. There were no differences in urea nitrogen or
creatinine levels between ad libitum—fed or pair—fed controls
rats so their urea and creatinine data were pooled.
To separate the effects of uremia from those of diminished
food intake, in some experiments the rats were paired by wt
after the first surgery. Both groups weighed an average of 102
2 g after the second surgery, and fifteen days later they weighed
174 5 g. The linear rate of body wt gain was therefore
identical in both groups (5.8 g/day).
Previously reported work from this laboratory indicated that
chronically uremic rats responded much more dramatically to
24 of 48 hr starvation than did control animals [111. Table 2
presents the body wt changes in response to fasting. As a
percentage loss in wt, the uremic rats lost more wt than the ad
0)
>-00
Table 1. Plasma concentrations of urea nitrogen and creatinine in
sham—operated and uremic rats
° Mean SE of 6 to 23 rats. Sham-operated rats include ad libitum
and pair—fed rats.
b P < 0.01 vs. sham-operated rats, same feeding conditions.
° P < 0.01 vs. fed sham-operated rats.
"P < 0.005 vs. fed uremic rats.
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Table 2. Body weights of uremic rats compared to sham—operated controls
Body wt % Loss of wt
Fasted Fasted
Treatment Fed 24 hr 48 hr 24 hr 48 hr
Experiment /
Sham ad libitum—fed 232 5 208 200 4b l0.5 0.9 16.4 1.0
Uremic 167 6C 141 5b.c 130 6bc 14.5 0.9" 25.5 1.0"
Experiment 2
Sham pair—fed 191 7 167 154 6" 12.4 0.5 19.3 0.6"
Uremic 190 5 159 5b 139 5b,a 16.3 0.6" 27.3 08d,f
Mean SE of 12 to 20 rats.
b P < 0.01 vs. fed rats given the same treatment.
P < 0.001 vs. sham—operated, ad libitum—fed control.
"P < 0.05 vs. sham—operated, ad libitum—fed control by ANOVA at the same time point.
P < 0.05 vs. sham—operated, pair—fed control.
P < 0.05 vs. sham—operated, pair—fed control by ANOVA at the same time point.
Table 3. Effect of uremia and food deprivation on protein synthesis and degradation in rat skeletal muscle
Experiment Controls Uremic Pa
Protein synthesis, nmoles Phe incorporated/hrlg muscle
I Fed (— insulin) 37 7 (8)" 47 9 (9) NS
2 Fed (-t- insu1in) 56 5 (11) 70 14 (6) NS
3 Ad libitum—fed, fasted 24 hr 47 2 (3) 30 2 (3) <0.01
4 Ad libitum—fed, fasted 48 hr 37 2 (6) 28 2 (6) <0.05
5 Pair—fed, fasted 48 hr 32 4(11) 25 3 (11)d NS
Protein degradation, nmoles Phe incorporated/hrlg hemicorpus
I Fed (— insulin) 139 9 (8) 156 10 (9) NS
2 Fed (+ insulin) 94 4 (Il) 106 6 (6) NS
3 Ad libitum—fed, fasted 24 hr 128 26 (3) 191 9 (3) <0.05
4 Ad libitum—fed, fasted 48 hr 150 18 (6) 212 24 (6)d <0.05
5 Pair—fed, fasted 48 hr 145 18(11) 193 18(11) <0.05
Net release, nmoles Phe incorporatedlhr/g hemicorpus
I Fed (— insulin) 55 7 (8) 64 7 (9) NS
2 Fed (+ insulin) 2 1(11) 5 2 (6) NS
3 Ad libitum—fed, fasted 24 hr 43 14 (3) 116 19 (3)" <0.02
4 Ad libitum—fed, fasted 48 hr 88 10 (6)" 140 23 (6)" <0.05
5 Pair—fed, fasted 48 hr 77 16(11)" 126 16(11)" <0.05
a pvalue for control vs. uremic.
b Mean SE (N).
Insulin was added to the perfusate at a final concentration of 25 mU/mliter. All other perfusions performed without insulin.
P < 0.05 vs. fed state.
libitum—fed control rats after both 24 and 48 hr of fasting, This
wt loss was also reflected in the decline of eviscerated carcass
wt, a measure of peripheral tissue mass. After 48 hr of fasting,
the carcass wt of uremic rats decreased 15% compared to only
4% in ad libitum controls. When comparing wt losses in uremic
and pair—fed controls, wt losses were still greater after 48 hr of
fasting in the uremic rats.
Plasma urea nitrogen and creatinine concentrations were
determined in the fasted rats (Table 1). In the control groups
creatinine levels were not significantly different after 48 hr of
starvation. Plasma urea nitrogen concentrations increased 61%
in the control rats and 94% in the fasted uremic rats. This was
accompanied by a slight, unexplained decrease in the plasma
creatinine concentration.
Protein synthesis and degradation rates were determined in
vitro in the perfused hemicorpus preparation. Several different
experiments were performed to look for differences between
control and uremic rats. Using phenylalanine as the marker for
protein metabolism, we perfused preparations from control and
uremic animals both in the presence and absence of pharmaco-
logical levels of insulin (Table 3). When studied in the fed state
without the addition of insulin, there were no discernible
differences between rates of gastrocnemius protein synthesis,
hemicorpus protein degradation or net phenylalanine release
between perfusions of uremic or ad libitum—fed control rats.
Perfusion in the absence of insulin resulted in slightly, although
not significantly, higher rates of protein synthesis in the prep-
arations from uremic rats. In both control and uremic prepara-
tions, perfusion in the presence of insulin resulted in a 50%
increase in the rate of protein synthesis, and a 33% decline in
protein degradation rates. Net phenylalanine release decrease
to near zero in both cases.
When starved for 24 or 48 hr, protein synthesis rates were
lower in the uremic rats than in our ad libitum—fed controls (P
< 0.01 and 0.05 respectively), but not significantly different
than those determined in our pair-fed control group (Table 3). In
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addition, after either 24 or 48 hr of fasting, our uremic animals
had significantly higher rates of both protein degradation and
net phenylalanine release than either the ad libitum or pair—fed
controls. After 48 hr of fasting, the protein degradation rate
averaged 37% higher in the uremics than the controls and net
release averaged 62% higher. This greater net release of phen-
ylalanine in preparations from uremic rats represents a more
negative nitrogen balance in vitro.
During several perfusions, Ntmethylhistidine was also mea-
sured. Uremic rats had higher initial plasma levels of N1-
methylhistidine and muscle levels of were still elevated over
control values at both 1 and 3 hr of perfusion. Perfusate
Ntmethylhistidine levels were higher in our preparations from
uremic rats at both time points and calculated degradation rates
were also increased. The increase in myofibrillar degradation in
uremic versus ad libitum—fed control was still apparent when
perfusate levels were corrected for the change in muscle free
N1-methylhistidine, 0.36 0.06 vs. 0.22 0.04 nmole releas-
ed/hr/g hemicorpus (P < 0.05). This study, performed in the
absence of gastrointestinal tissue demonstrates that two specific
proteins of muscle, actin and myosin, are degraded at a faster
rate in fed uremic rats.
We attempted to examine the reasons sham and uremic rats
responded differently to food deprivation. Since food intake
was decreased in our uremic rats, undernutrition appeared to be
an important factor. One measure of malnutrition is the lack of
lipid deposition within an animal. In fed rats, the amount of fat
found in the ad libitum control group was 45% greater than in
carcasses of uremic rats (54.0 4,1 vs. 29.6 1.2mg lipid/g
carcass, respectively). After a 48 hr fast, total body lipids
decreased in both groups to 22.5 8.6 and 14.7 2.3 mglg
carcass in the shams and uremic rats respectively. Unlike the
changes seen for total body lipid, carcass protein contents were
similar in both ad libitum control and uremic rats, averaging 176
4 and 166 2 mg protein/g carcass respectively. These
values did not change appreciably after 48 hr of starvation.
It was difficult to measure total carcass lipid in the same
experiments where other determinations were also being car-
ried out so an alternate index of total lipid content was sought.
The epididymal fat pads are easily obtained without destroying
the hemicorpus preparation. As noted in Figure 2, the correla-
tion between the total carcass lipid and the wt of the epididymal
fat pads was quite good (r = 0.83) for ad libitum control,
uremic, fed or fasted rats. In Table 4, the wts of the epididymal
fat pad are given as a percentage of the total body wt. In each
situation, the combined wt of the two fat pads were significantly
greater in the control than in the uremic rats, suggesting
decreased total lipid content in our uremic group.
In Figure 3 we correlated the percentage loss in body wt after
48 hr of fasting (A) and the rate of protein degradation at that
time (B) with the wt of the epididymal fat pads. The greatest
loss in body wt is associated with the lowest lipid content in the
body. This correlation was quite good for the uremic rats (r =
0.81), but not significant for the ad libitum control animals (r =
0.19). The relationship between the rate of protein degradation
and the wt of the fat pads indicated that protein degradation was
also greatest when the lipid content of the carcass was low.
These data suggest that the accelerated catabolism seen in our
stressed uremic rats may be a function of their lower levels of
body lipid.
60 80
Carcass lipid, mg/g
Fig. 2. The relationship between epididvmal fat pad wt and total
carcass lipid. Sham (o) or uremic (x) rats were either fed or fasted 24 or
48 hr. The combined weight of the two epididymal fat pads was
expressed as a percentage of the body weight. From the same rats, the
lipids were extracted from the eviscerated, skinned carcasses. The line
was determined by linear regression.
Table 4. Epididymal fat pad wts in sham and uremic rats
Controls Uremic P
Fed 0.657 0.078 (6) 0.455 0.027 (8) <0.02
Fasted 24 hr 0.532 0.063 (3) 0.322 0.047 (3) <0.05
Fasted 48 hr 0.341 0.022 (4) 0.158 0.033 (4) <0.002
Pair—fed.
fasted 48 hr 0.367 0.233 (17) 0.132 0.021 (17) <0.001
a Mean SE (N).
Discussion
In our uremic animals, both plasma urea nitrogen and creat-
mine levels were four times higher than normal and in the same
range as reported by others [21—23]. This degree of renal failure
was associated with decrease food intake and diminished wt
gain as compared to the ad libitum—fed controls. In spite of the
decreased wt gain seen when compared to the ad libitum—fed
group, we were unable to demonstrate any difference between
the uremic animals and that group of fed controls (Table 3). We,
as well as other groups have noted that when control rats are
fed the same quantity of food eaten by their moderately uremic
mates, growth rates are equivalent [21, 22]. When the study
period is prolonged to six weeks [23] or when more severe
degrees of renal failure are induced [24], uremic rats then gain
less wt than their pair—fed controls. Using the same model
employed by us, Adelman and Holliday demonstrated that
calorie supplementation is associated with increased wt gain in
uremic rats [25]. Thus, for rats with moderate renal insuffi-
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Fig. 3. The relationship between lipid content and loss of body wt or
rate of protein degradation. A. Body weight loss correlates with lipid
content in the uremic (x), but not in the sham (0) rats. B. The rate of
protein degradation shows some correlation with lipid content (r =
0.55).
ciency, the early decrease in wt gain appears to be a function of
diminished food intake.
It is probable that the inability of our phenylalanine methods
to detect changes in protein turnover is related to the small
absolute differences in turnover rates present during the 2 hr
perfusion period. The uremic and pair—fed rats gained 2.1 g/day
less than the ad libitum—fed controls. When expressed as the
difference in growth rates over a mean wt of approximately 150
g, this translates into only a 0.1% difference in net protein
anabolism over the 2 hr perfusion period (2.1 g/150 gIl2 x 100).
Given the interanimal variability present in our model, it is not
surprising therefore, that changes in body wt averaged over
days could not be demonstrated during two hr of perfusion.
Our determination that Ntmethylhistidine release was in-
creased in the fed uremic animals suggests that at least two
proteins, actin and myosin, are being degraded more rapidly in
chronic renal failure. When actomyosin degradation was mea-
sured in the perfused hemicorpus, preparations from uremic
rats had faster rates of Ntmethylhistidine release than ad
libitum controls, supporting earlier data from our laboratory in
which the urinary excretion of N'.methylhistidine was mea-
sured from chronically uremic and sham—operated rats [11]. In
those experiments, the ratio of Ntmethylhistidine/creatinine
(mole/mole) excreted into urine in 24 hr was 0.67 in uremic rats
and 0.53 in sham rats, a 21% decrease. When the absence of
gastrointestinal tissue and the possibility of some metabolism of
creatinine by our uremic rats is taken into account, our in vivo
and in vitro determinations are certainly within the same range.
Initially, the in vitro data on Nt-methylhistidine release seem
to be in contradiction with the lack of observed differences in
phenylalanine release when fed animals are studied. The use of
Ntmethylhistidine is, however, a specific measure of actomy-
osin degradation. In several physiologic states, changes in
Ntmethylhistidine release from rat muscle has been shown to
be more dramatic than changes in phenylalanine release [26].
When this amino acid is released during protein degradation, it
cannot be reincorporated into proteins [27], thus eliminating an
artifact which underestimates rates of protein degradation de-
termined using other amino acids [28].
Finally, it must be recognized that phenylalanine and Nt
methylhistidine are distributed quite differently within body
proteins. Phenylalanine is presumed to be present within all
body proteins and these proteins are degraded at a wide variety
of rates. Ntmethylhistidine is found only within actin and
myosin, two structural muscle proteins known to have long
half—lives [12, 26]. Therefore, an increase in the degradation of
long—lived proteins that results in a significant increment in
Ntmethylhistidine release may result in only a modest incre-
ment in the total quantity of protein degraded. When the nmoles
of Nt-methylhistidine are converted to phenylalanine equiva-
lences [26], preparations from uremic rats released about 21
nmoles of phenylalanine equivalents/hr/g compared to 13 for the
shams. This difference of only 8 nmole/hr/g in a total of 156
nmoles of phenylalanine/hr/g is difficult to detect with any
degree of certainty.
In previous work, we reported that starvation led to an
exaggerated loss of body wt and an increase in the excretion of
urinary Nt-methylhistidine when compared to that seen in
control rats [11]. In this study, using direct measurements of
protein turnover in the peripheral tissues of fasted rats, we have
been able to demonstrate that uremic animals had lower rates of
protein synthesis and higher rates of protein degradation than
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fasted controls. Together these changes in protein synthesis and
degradation resulted in a greater net release of phenylalanine,
indicating that the muscle of fasted, uremic rats was in more
negative nitrogen balance than the muscle of fasted, sham—op-
erated control animals.
Unfortunately, it was technically impossible to measure
Ntmethylhistidine release from perfused hemicorpus prepara-
tions of fasted uremic rats. The intracellular concentration of
Ntmethylhistidine is greatly elevated within the muscle of
starved animals [11]. During perfusion, this intracellular free
Ntmethylhistidine diffuses out of the cells in sufficient quantity
to mask the ongoing production of Ntmethylhistidine released
from muscle during myofibrillar degradation.
Holliday et al [29] studied urea production and muscle protein
synthesis rates in vivo, in chronically uremic, starved rats.
They found similar rates of muscle protein synthesis in their fed
uremic and control rats, However, after a 36 hr fast urea
production was increased and muscle protein synthesis rates
decreased in their uremic as compared to fasted controls. These
results confirm and extend those findings.
Other workers using perfused or incubated muscle prepara-
tions from acutely uremic rats have reported decreased rates of
protein synthesis [9] and increased rates of protein degradation
[9, 301 when compared to controls. There are several differ-
ences between the chronic and acutely uremic rat models. The
first is that the acutely nephretomized animals are also fasted
between time of surgery and the in vitro experiment. The
chronically uremic rats have had time to adapt to their renal
insufficiency and to resume growth. Second, while in itself
non-toxic, BUN levels may be an indication of the presence of
other possible "uremic factors". These levels are certainly
higher in the acutely nephrectomized, fasted animals than in the
fed, chronically uremic model.
Our experiments were not designed to compare the effects of
feeding or fasting on rates of protein synthesis and degradation
but rather to compare control and uremic rats prepared in the
same physiological state and compared within the same perfu-
sion study. The inter-experiment variability makes it difficult to
show statistical significance between preparations from fed and
fasted rats except where large changes occurred. When control
or uremic rats were compared within the same study, the
addition of insulin significantly increased protein synthesis,
decreased protein degradation and net release rates.
Significant concentrations of insulin are present in vivo in fed
animals while insulin levels drop early in the course of starva-
tion. Therefore, when insulin is absent from the medium,
synthesis rates determined in hemicorpuses obtained from fed
animals probably underestimate the true rate of protein synthe-
sis. When all our data on protein synthesis and degradation are
compiled, fasting uremic rats for 48 hr caused a 60% decrease in
synthesis compared to fed rats perfused with insulin (P <0.01)
and an 80 to 100% increase in degradation after 24 to 48 hr
fasting (P < 0.05). The preparations from sham rats showed
34% decrease in synthesis compared to perfusions with insulin,
and a 60% change in degradation after 48 hr of fasting. In both
cases these led to a significant change in the net release of
phenylalanine from the hemicorpus system.
The effects of starvation on protein turnover within muscle
have been studied in some detail. Protein degradation rates
increased earlier in smaller, younger rats [331 but may not
increase for several days in older animals [31—33]. For this
reason, in our studies we always compared aged—matched
animals and attempted to control for wt by pair—feeding. With
prolonged starvation, the muscle's capacity to synthesize pro-
tein further decreases due to a decrease in RNA concentration
[31, 34]. In the fed state, muscle RNA concentrations were
similar in our control and uremic rats both before and after 48 hr
of starvation (Wassner and Li, unpublished observations).
In humans [35, 361 and older or obese animals 133], the first
few days of total starvation are characterized by increased
nitrogen excretion and the release of amino acids from skeletal
muscle. Thereafter, the second phase is characterized by de-
creased nitrogen excretion and increased utilization of lipids.
This results in the accumulation of free fatty acids and ketone
bodies in the plasma [33, 35, 36]. Finally, when plasma ketone
levels decrease, protein degradation increases rapidly and death
follows [32, 331. The earlier increase in muscle catabolism seen
in younger animals is probably related both to their higher
metabolic rates and smaller initial stores of body lipid [33].
The loss of body wt in our uremic rats was inversely related
to the amount of lipid they possessed. This relationship did not
seem to apply to our control rats. It is possible that the loss of
body wt is linearly related only at low concentrations of body
fat (that is, epididymal fat pads of less than 0.3% of the body wt
or total carcass lipid less than 15% of body wt).
In spite of the equivalent wt gain, when starved, our uremic
rats still lost more wt than the pair—fed control group. While
epididymal fat pad wts were not measured in non-fasted
pair—fed control rats, even at 48 hr their fat pad wts were
significantly higher than those of the uremic rats and no
different than seen in fasted ad libitum controls. Maloff, Mc-
Caleb, and Lockwood have reported that epididymal fat cells
taken from uremic rats have decreased lipogenic activity when
assayed in vitro [37]. In addition, the same group recently
reported that the addition of dialyzed serum extracts obtained
from humans with chronic renal failure inhibited lipogenesis in
vitro in epididymal fat cells taken from rats with normal renal
function [38]. By subtracting the epididymal fat pad wts of our
control and uremic rats from the values determined in our fed
animals, we can obtain crude estimates of the rates of lipolysis
within those tissues. These rates are approximately equal and
agree with the suggestion that lipolysis rates are normal in
uremia [36]. Thus, decreased fat stores may condition the
exaggerated catabolic response seen during periods of stress. It
is possible that in chronic renal failure a major problem may be
poor nutrition with either inadequate caloric intake or alteration
in energy metabolism and fat deposition [38]. In the unstressed
state, moderate chronic renal insufficiency by itself may not be
devastating to growth. However, when stressed as by starva-
tion in the present studies, or with intercurrent illness, acceler-
ated protein catabolism is evident sooner and to a greater
degree in uremic individuals. This problem would be particu-
larly serious in early life during the periods of most rapid
growth, at a time when infants with chronic renal failure are
thought to suffer their greatest loss of growth potential.
Whether the decreased deposition of fat stores is secondary to
decreased nutritional intake or is a feature of uremia per se, is
unclear, but certainly deserves further study.
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